Original Research ReportKi-67 labeling index in glioblastoma; does it really matter?

Add time:08/17/2019    Source:sciencedirect.com

Objective/BackgroundGlioblastoma (GB) is the most common primary malignant brain tumor in adults. Ki-67 is a nonhistone nuclear protein that is expressed by cells entering the mitotic cycle and is associated with the transcription of ribosomal RNA (rRNA). In gliomas, the extent of expression of Ki-67 is roughly proportional to the histologic grade. Over the years, association studies were conducted trying to link the poor outcome in different types of malignant tumors to the Ki-67 proliferative index. This study is designed to investigate the relationship between the proliferation marker, Ki-67, and the overall survival amongst glioblastoma patients diagnosed between 2006 and 2012 at a single institution in Riyadh, Saudi Arabia.

We also recommend Trading Suppliers and Manufacturers of GB 67 (cas 116784-70-4). Pls Click Website Link as below: cas 116784-70-4 suppliers

Prev:Rapid identification of amino acid derivatives from the sequenator
Next:Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial)